NeuronAlgo
~/backtests/na-nas-l-009 backtest

$ cd /evidence  ·  evidence archive

Backtest evidence

Hamal

code: NA-NAS-L-009 NasdaQ_Oanda H1 2006-01-02 → 2026-06-19
net $17,891 trades 709 win 55.65%
at-a-glance --summaryok

$ stats --glance

headline performance at a glance

net_profit
Total net profit $17,891
gross profit$64,436
gross loss$46,545
win_rate
55.65%WIN
██████░░░░
Win rate
394W / 314L
profit_factor
1.38PF
█████░░░░░
Profit factor
gross P / gross L
cagr
5.26%CAGR
██░░░░░░░░
CAGR
annualized
max_drawdown
-22.64%MAX DD
██░░░░░░░░
Max drawdown
$2,735
equity_curve --renderok

$ plot --equity

cumulative account equity over the test window

Stored snapshot: 1,418 points; starts at $10,000.00, ends at $27,890.55; observed range $9,074.62–$27,928.85.

x: time · y: equity (USD)● rendered by na-backtest-charts

$ plot --drawdown

underwater equity (peak-to-trough), in account currency — risk per trade is a fixed dollar amount, so a percent axis would shrink every year as the balance grew

x: time · y: drawdown (USD)● rendered by na-backtest-charts
trade_breakdown --analyzepartial

$ trades --breakdown

win/loss split, averages, and streaks

win_loss_split
55.65%win
Wins394
Losses314
Total709
win_vs_loss_size
Avg win$163.54
Avg loss$148.23
Largest win$674.52
Largest loss-$222.04
key_ratios
Profit factor1.38
Win/Loss ratio1.25
Payout ratio1.10
Expectancy$25.23
Avg trade$25.23
Bars in trade11.87
streaks
Max consec wins12
Max consec losses6
Avg consec wins1.00
Avg consec losses1.00
Long vs short breakdown and per-trade distributions are not in the ingested dataset yet.
full_statistics --allok

$ stats --full

complete metric set, grouped by category

$17,891
Net profit
$64,436
Gross profit
$46,545
Gross loss
5.26%
CAGR
8.52
AHPR
$895
Yearly avg profit
$73
Monthly avg profit
$2.39
Daily avg profit
8.95%
Yearly avg return
6.53%
Exposure
709
Trades
$25.23
Avg trade
run.configok

$ cat run.config

parameters used for this run

instrumentNasdaQ_Oanda
timeframeH1
period start2006-01-02
period end2026-06-19
profit in pips162301.94 ticks
strategyview →
Trading financial instruments carries a high level of risk and may not be suitable for all investors. Past performance — including backtested and simulated results — is not indicative of future results. NeuronAlgo provides research and tooling, not financial advice.
nextok

Explore the strategy behind this run

See the full methodology, risk profile, and live track record — or browse every backtest in the library.

Generated from stored backtest metrics · NeuronAlgo research desk

Scroll to Top